Tizanidine Tablet
Product Images NDC 50090-2078
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 50090-2078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 02
Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 03
Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 04
This document reports on the improvement in Ashworth Score, which is a measure of spasticity in patients. The dosage used in the study was 26.8 mg, and measurements were taken at the End of Titration (Study Week 3), End of Maintenance (Study Week 7), and Endpoint (Last Observation Carried Forward).*
Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 05
Label Image (Lbl500902078)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.